Table 2 Treatment and gender classification
Treatment | Patients n (%) | Male n (%) | Female n (%) |
|---|---|---|---|
IFNβ-1a | 10 (19.2) | 1 (10) | 9 (90) |
Glatiramer acetate | 11 (21.2) | 4 (26.4) | 7 (63.6) |
Fingolimod | 15 (28.8) | 4 (26.7) | 11 (73.3) |
Dimethyl fumarate | 11 (21.2) | 3 (27.3) | 8 (72.7) |
Treatment-naïve | 5 (9.6) | 1 (20) | 4 (80) |